![Ronald Ellis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Ellis
Geen lopende functies
Profiel
Ronald W.
Ellis worked as an Executive Director at Merck Research Laboratories Massachusetts LLC from 1982 to 1996.
He was also a Principal at Astra LLC from 1994 to 2011.
In addition, he held the position of Senior Vice President of Research & Development at AVANT Immunotherapeutics, Inc. in 2006-2007.
He was the CTO and SVP of Research & Development at SciSparc Ltd. from 2007 to 2013, and the Chief Technology Officer at FutuRx Ltd. in 2013-2014.
Ellis received his undergraduate degree from The University of Chicago, his doctorate from Cornell University, and his MBA from the University of Maryland.
Eerdere bekende functies van Ronald Ellis
| Bedrijven | Functie | Einde |
|---|---|---|
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Hoofd Techniek/Wetenschap/O&O | 02-01-2014 |
| SCISPARC LTD. | Hoofd Techniek/Wetenschap/O&O | 31-12-2013 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Hoofd Techniek/Wetenschap/O&O | 31-07-2007 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Astra LLC
 Astra LLC Wholesale DistributorsDistribution Services Manufactures refrigeration systems | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ronald Ellis
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
47
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Astra LLC
Astra LLC Wholesale DistributorsDistribution Services Manufactures refrigeration systems | Distribution Services |
SciSparc Ltd.
 SciSparc Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative vaccines and immunotherapy products | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
